Mutual Pharmaceutical Company

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Mutual Pharmaceutical Company sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).

27 total trials none currently recruiting 26 completed early-phase tilt top decile by trial count

Mutual Pharmaceutical Company: 27 sponsored US clinical trials, none currently recruiting.

Mutual Pharmaceutical Company sponsors 27 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 26 completed. 0 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pharmacokinetics, with 2 trials.

Top-decile sponsor footprint

Mutual Pharmaceutical Company ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 81/100

26 of 27 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

27 total, page 1 of 1

COMPLETED Phase 1

A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz

NCT01472380
COMPLETED Phase 1

Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients

NCT01075906
COMPLETED Phase 1

Bioavailability Study of Colcrys® Crushed and Sprinkled on Applesauce

NCT01130051
COMPLETED Phase 1

Bioavailability Study of Colcrys® in Apple Juice

NCT01123395
COMPLETED Phase 1

Drug-Food Interaction Study of Seville Orange Juice and Colchicine

NCT00960193
COMPLETED Phase 1

Drug-Drug Interaction Study Between Colchicine and Atorvastatin

NCT00960323
COMPLETED Phase 1

A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice

NCT00984009
COMPLETED Phase 1

Drug-Drug Interaction Between Colchicine and Verapamil ER

NCT00983242
COMPLETED Phase 1

Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone

NCT00785213
COMPLETED Phase 1

Drug-Drug Interaction Study of Colchicine and Theophylline

NCT00983905
COMPLETED Phase 1

Drug-Drug Interaction Study Between Colchicine and Cyclosporine

NCT00983931
COMPLETED Phase 1

Drug-Drug Interaction Study Between Colchicine and Diltiazem ER

NCT00983372
COMPLETED Phase 1

Drug-Drug Interaction Study Between Colchicine and Ketoconazole

NCT00983216
COMPLETED Phase 1

Drug-Drug Interaction Between Colchicine and Ritonavir

NCT00983515
COMPLETED Phase 1

Drug-Drug Interaction Study of Colchicine and Clarithromycin

NCT00984061
COMPLETED Phase 1

Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study

NCT01018420
COMPLETED Phase 1

Four Arm Food Effect Study of Fenofibric Acid Tablets

NCT00960856
TERMINATED Phase 1

Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment

NCT00785551
COMPLETED Phase 1

Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

NCT00961116
COMPLETED Phase 1

Pharmacokinetic Study of an Acute Gout Regimen

NCT01017042
COMPLETED Phase 1

Pharmacokinetic Study With Colchicine in Healthy Volunteers

NCT01017003
COMPLETED Phase 1

Bioequivalence Study of Colchicine Tablets

NCT01021020
COMPLETED Phase 1

A Pharmacokinetic Study of Colchicine With an Oral Contraceptive

NCT01040845
COMPLETED Phase 1

Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline

NCT00779259
COMPLETED Phase 1

Drug-Drug Interaction Study of Qualaquin and Midazolam

NCT00785486
COMPLETED Phase 1

Fed Bioavailability Study of Zonisamide Capsules

NCT00687167
COMPLETED Phase 1

A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions

NCT00727272

Phase Distribution

PhaseTrial count
Phase 1 27

Therapeutic Areas

Pharmacokinetics 2
Familial Mediterranean Fever 1
Healthy 1

How the Mutual Pharmaceutical Company early-phase archive is shaped

27 indexed studies, none listed as recruiting (0% open); 26 completed (96%).

Phase mix: 0 late (III/IV) vs 27 early (I/II) (early-phase heavy).

Top condition: Pharmacokinetics (2 trials), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Mutual Pharmaceutical Company: archived-pipeline peers nationwide

Peers matched on 27 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Mutual Pharmaceutical Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030 0%5%10%15%20% Total trials Recruiting share Mutual Pharmaceutical CompanyAkron Children's HospitalArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)AVEO PharmaceuticalsDompé Farmaceutici S.p.A10xBio22nd Century Group23andMe3-C Institute for Social Development
Mutual Pharmaceutical Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Mutual Pharmaceutical Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 27 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Mutual Pharmaceutical Company page

27 registered trials is a research-attention snapshot, not an endorsement of Mutual Pharmaceutical Company or any single study.

  • None of Mutual Pharmaceutical Company's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Pharmacokinetics is the condition Mutual Pharmaceutical Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pharmacokinetics trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mutual Pharmaceutical Company pipeline card: 27 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.